Severe Chronic Neuropathic Pain: A Treatment Bundle, Using Spinal Cord Stimulation and Multidisciplinary Treatment, to Reduce Pain and Improve Physical Function. (SCS-R)

University of Oslo (UIO)

Status

Enrolling

Conditions

Multidisciplinary Approach

Acceptance & Commitment Therapy

Neuropathic Pain

Spinal Cord Stimulation (SCS)

Rehabilitation Exercise

Treatments

Other: Treatment bundle

Study type

Interventional

Funder types

Other

Identifiers

NCT07403331

942321

Details and patient eligibility

About

People with nerve damage can develop nerve pain. The pain can sometimes be severe and unpredictable, causing odd or alarming sensations - for example, lightning-like or electric shock feelings in the area served by the damaged nerve.

The investigatyors will examine a treatment for nerve pain in the legs caused by nerve damage, which can occur after a herniated disc or a bone fracture, with or without surgery.

Previous research suggests that spinal cord stimulation can relieve nerve pain in the legs after surgery or injury, but its effectiveness is still debated. Other studies show that multidisciplinary treatment helps people with long-term pain to improve their quality of life and to better cope in life. National and international guidelines recommend this kind of multidisciplinary care for long-term pain.

There has yet been published research on spinal cord stimulation combined with multidisciplinary treatment as a bundle intervention. The investigators therefore want to find out whether this combined approach can reduce nerve pain in the legs and improve physical functioning.

Enrollment

10 estimated patients

Sex

All

Ages

18 to 60 years old

Volunteers

No Healthy Volunteers

Inclusion criteria

Peripheral neuropathic pain in one or both legs for >6 months due to:
- (1) Post Spinal Pain Syndrome (type 1 or 2).
- (2) Localized nerve damage.
The area of the neuropathic pain in the leg(s) must be the dominant pain component.
Age ranges from 18-60 years.
Previous standard conservative (or surgical) treatment attempted.
Opioid use within permissible limits at implantation time (daily opioid dose <50 mg OMEQ).
Willingness to actively participate in the treatment bundle.
Living within reasonable travelling distance from Oslo.
Proficiency in understanding oral and written Norwegian, essential to benefit from the program that relies on mutual comprehension, nuanced conversation, and emotional expression, which are language-dependent.
Cognitive capacity to provide informed consent.
Ability to master the technical aspects of the SCS system (switching programs on the remote control).

Exclusion criteria

Currently undergoing the claims process for health benefits (e.g., disability pensions from NAV (Norwegian Labour and Welfare Administration).
Presenting a psychological or psychiatric disorder that may impact treatment efficacy.
Chronic generalized pain conditions.
Other pain conditions in the affected area, such as osteoarthritis.
Pregnancy.